JVJavier Velasco

Javier Velasco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Javier Velasco has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Discovery, Characterization, and Quantification of Bioactive Peptides Contained in Palbio Porcine Intestinal Mucosa Hydrolysate Products

    by Sergi Segarra, Carolina de la Torre, Joan Josep Bech-Serra, Bernat Cucurull, Anna Marazuela-Duque, Alejandro Vaquero, Daniel Martínez-Puig, Javier Velasco-Alvarez

    Porcine intestinal mucosa hydrolysates (PIMHs) are by-products of heparin production obtained through a specific enzymatic hydrolysis process, which can theoretically generate bioactive peptides (BAPs). This study aimed to identify, characterize, and quantify BAPs in two Palbio products manufactured by Bioiberica S.A.U. (Palafolls, Spain), which are PIMH protein sources used for animal feed: Palbio® HP (PHP) and Palbio® 62 SP® (P62). Using mass spectrometry (MS)-based peptidomics, we analyzed three samples from each product, fractionated based on molecular weight (10 kDa). The <3 kDa fraction was analyzed directly, while the other two fractions were enzymatically digested before MS analysis. The workflow identified 961 peptides in PHP and 1134 in P62. Subsequent bioinformatic analysis using public databases (APD2, StraPep, AHTPDB, and BIOPEP-UWM) led to the identification of six significant BAPs in both PHP and P62, with respective quantified amounts (pg peptide/μg sample): DAVEDLESVGK (0.1626, 0.1939), EGIPPDQQRLIFAGK (0.2637, 0.1852), TITLEVEPSDTIENVK (0.3594, 0.4327), TNVPRASVPDGFLS (1.4596, 0.1898), TNVPRASVPDGFLSEL (8.0500, 0.9224), and VHVVPDQLMAF (0.0310, 0.0054). The first three BAPs are related to antimicrobial activity, while the latter three are associated with cytokine/growth factor-like, antioxidant, and immunomodulatory activities. These bioactivities align with previously reported in vivo benefits observed in animal nutrition using Palbio products. Our findings demonstrate that PHP and P62 are valuable sources of BAPs, supporting their potential role in improving animal health and performance.


  • Open Access

    Lettuce Soil Microbiome Modulated by an L-α-Amino Acid-Based Biostimulant

    by Marta Acin-Albiac, Beatriz García-Jiménez, Cándido Marín Garrido, Elisabet Borda Casas, Javier Velasco-Alvarez, Nuria Sierras Serra, Alberto Acedo

    Maintenance of soil health is of foremost importance to sustain and increase crop productivity, while meeting the demand of a rising global population. Soil microbiome is gaining increasing attention as a modulator of soil health. Microbial communities confer traits to the soil as a living organism, which functions holistically and conforms part of the plant holobiont, reassembling the human-gut axis. Novel strategies in biostimulant development advocate for modulation of the native soil microbiome and the reinforcement of microbial networking to outpace pathogen inclusion. Consequently, we hypothesize that Terramin® Pro may promotes beneficial microorganisms, depending on the native microbiota of soil, which would lead to an improvement of crop performance indicators. We proposed a soil microbiome-based approach to characterize the effect of an L-α-amino acid based biostimulant (Terramin® Pro) on resulting plant phenotypes in lettuce cultivars (Lactuca sativa L.) to address our hypothesis. First, product application promoted Actinobacteria group in assorted soils with different track of agronomic practices. Secondly, biostimulant application improved chlorophyll content in particular soils deviating from standard conditions, i.e., sick or uncultivated ones. Specially, we observed that product application at 30 L ha−1 improved lettuce phenotype, while potentially promoted entomopathogenic fungi (Beauveria and Metarhizium spp.) and suppressed other lettuce disease-related fungi (Olpidium spp.) in nematode-infested soils. Further investigations could deepen into Terramin® Pro as a sustainable prebiotic strategy of soil indigenous microbiota, through in-house microbiome modulation, even in additional crops.


  • Open Access

    Significant Discrepancies in “Functional Characterization of Undenatured Type II Collagen Supplements: Are They Interchangeable?”: A Rejoinder

    by Javier Velasco-Alvarez

    In 2021, an article was published comparing two commercial products containing undenatured type II collagen: b-2Cool® (Bioiberica, S.A.U., Barcelona, Spain; designated CII-X, X1, and X2) and UC-II (Lonza Consumer Health Inc, USA; designated CII-Y, Y1, and Y2). However, we feel certain concerns remain where clarification may be warranted.


  • How Statins Could Be Evaluated Successfully in Clinical Trials for Alzheimer’s Disease?

    by Javier S. Burgos, Jesús Benavides, Patrice Douillet, Javier Velasco, Fernando Valdivieso

    Over the last decade, a large number of experimental observations have suggested a relationship between alterations in cholesterol homeostasis and Alzheimer’s disease (AD). Moreover, epidemiological studies have pointed an association between statin treatment and a decrease in the risk of having AD. For these reasons, a large number of clinical trials have been carried out to determine whether the statins can prevent the progression of AD. However, these studies did not provide clear evidence for the therapeutic efficacy in AD. We consider that there are a number of explanations for this failure that may provide guidance for selecting and clinically developing statins with therapeutic efficacy in AD.


  • Simvastatin Modulates the Alzheimer's Disease-Related Gene seladin-1

    by Maria C. Ramos, Saleta Sierra, Carlos Ramirez, Javier Velasco, Javier S. Burgos

    This work describes a novel mechanism of neuroprotection by simvastatin: the modulation of seladin-1, an enzyme involved in Alzheimer's disease. Genomic and proteomic studies in human neuronal cells showed seladin-1 production to be increased in a do


  • Metabolism of prebiotic products containing β(2-1) fructan mixtures by two Lactobacillus strains

    by Oscar Bañuelos, Layla Fernández, José M. Corral, Magdalena Valdivieso-Ugarte, José L. Adrio, Javier Velasco


  • Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis

    by Federico Lara-Villoslada, Oscar de Haro, Desire Camuesco, Mónica Comalada, Javier Velasco, Antonio Zarzuelo, Jordi Xaus, Julio Galvez

    Previous studies have demonstrated the anti-inflammatory effect of fructooligosaccharides (FOS) on intestinal inflammation. The aim of the present study was to elucidate whether the colonic fermentation of these carbohydrates is a pre-requisite for this anti-inflammatory activity. With this aim short chain-FOS (SC-FOS) were used for an in vitro fermentation to elucidate the time of fermentation of these compounds. For the in vivo experiments female Wistar rats were fed several diets with different sources of fibre (5 g/kg): cellulose for control rats (n = 30) or SC-FOS (n = 20) with a high content of kestose (GF2) for the SC-FOS group. After one month of feeding the different diets 10 rats from each group were sacrificed to analyze cecal and colonic microflora, SCFA production and pH of intestinal contents. A distal colonic inflammation was induced to other 10 rats from each group by the administration of 10 mg of TNBS dissolved in 0.25 ml of 50% ethanol (v/v). The rest of the rats from the control group (n = 10) were rendered healthy. One week after TNBS treatment rats were sacrificed and several inflammatory parameters as well as intestinal microbiota and SCFA contents were analyzed. In vitro fermentation experiments showed that SC-FOS are fermented during the first 12 h after incorporating the oligosaccharides to intestinal contents, thus suggesting a preferential fermentation of these carbohydrates in the ileum and cecum. In fact, SC-FOS increased cecal lactobacilli and bifidobacteria counts as well as SCFA production in healthy rats. In colitic rats, SC-FOS feeding caused a decrease of MPO activity, leukotriene B4 (LTB4) production and iNOS expression. This anti-inflammatory effect was evidenced macroscopically by a significant reduction in the extent of colonic damage. SC-FOS also promoted a more favorable intestinal microbiota, increasing lactobacilli and bifidobacteria counts. In conclusion, although oligosaccharides are preferentially fermented in the upper parts of the large intestine, its prebiotic effect is extended to the distal colonic segments, thus exerting a positive effect on colonic inflammation.


  • Open Access

    The isopenicillin N acyltransferases of Aspergillus nidulans and Penicillium chrysogenum differ in their ability to maintain the 40‐kDa αβ heterodimer in an undissociated form

    by Francisco J. Fernández, Rosa E. Cardoza, Eduardo Montenegro, Javier Velasco, Santiago Gutiérrez, Juan F. Martín

    The isopenicillin N acyltransferases (IATs) of Aspergillus nidulans and Penicillium chrysogenum differed in their ability to maintain the 40‐kDa proacyltransferase αβ heterodimer in an undissociated form. The native A. nidulans IAT exhibited a molecular mass of 40 kDa by gel filtration. The P. chrysogenum IAT showed a molecular mass of 29 kDa by gel filtration (corresponding to the β subunit of the enzyme) but the undissociated 40‐kDa heterodimer was never observed even in crude extracts. Heterologous expression experiments showed that the chromatographic behaviour of IAT was determined by the source of the penDE gene used in the expression experiments and not by the host itself. When the penDE gene of A. nidulans was expressed in P. chrysogenum npe6 and npe8 or in Acremonium chrysogenum, the IAT formed had a molecular mass of 40 kDa. On the other hand, when the penDE gene originating from P. chrysogenum was expressed in A. chrysogenum, the active IAT had a molecular mass of 29 kDa. The intronless form of the penDE gene cloned from an A. nidulans cDNA library and overexpressed in Escherichia coli formed the enzymatically active 40‐kDa proIAT, which was not self‐processed as shown by immunoblotting with antibodies to IAT. This 40‐kDa protein remained unprocessed even when treated with A. nidulans crude extract. In contrast, the P. chrysogenum penDE intronless gene cloned from a cDNA library was expressed in E. coli, and the IAT was self‐processed efficiently into its α (29 kDa) and β (11 kDa) subunits. It is concluded that P. chrysogenum and A. nidulans differ in their ability to self‐process their respective proIAT protein and to maintain the α and β subunits as an undissociated heterodimer, probably because of the amino‐acid sequence differences in the proIAT which affect the autocatalytic activity.